x

Coronavirus

BioNTech Increases Vaccine Production Estimates

BERLIN— German pharmaceutical company BioNTech says that after ramping up its manufacturing and supply systems, it expects to manufacture this year up to 2.5 billion doses of the coronavirus vaccine it developed with U.S. partner Pfizer.

The two companies had previously spoken of being able to make 2 billion doses in 2021.

Mainz-based BioNTech said Tuesday that it had delivered 200 million doses of the vaccine globally as of March 23 and signed orders for 1.4 billion doses for delivery in 2021. Discussions on further orders were ongoing, it said.

The company attributed the increased capacity to optimized production processes and the start of production at a new plant in Marburg, Germany; the expansion of its manufacturing and and supply network; and regulatory approval for six doses to be drawn from each vial, rather than five.

RELATED

ATHENS – While the New Democracy government is easing health restrictions for rabid anti-vaxxers, those fully vaccinated against COVID-19 may need a fourth shot in the autumn.

Top Stories

Columnists

A pregnant woman was driving in the HOV lane near Dallas.

General News

FALMOUTH, MA – The police in Falmouth have identified the victim in an accident involving a car plunging into the ocean on February 20, NBC10 Boston reported.

General News

NEW YORK – Meropi Kyriacou, the new Principal of The Cathedral School in Manhattan, was honored as The National Herald’s Educator of the Year.

Video

After Amazon, Google’s First Cloud Region Coming to Greece

ATHENS - Despite having a costly Internet that’s the slowest in the European Union, Greece is continuing to attract high-tech giants, with Alphabet’s Google planning to create its first cloud region in the country.

Enter your email address to subscribe

Provide your email address to subscribe. For e.g. abc@xyz.com

You may unsubscribe at any time using the link in our newsletter.